1. Catalogs
  2. Corning Life Sciences
  3. Corning® Supersomes? Human Carboxylesterase Portfolio
video corpo

Corning® Supersomes? Human Carboxylesterase Portfolio

Corning® Supersomes? Human Carboxylesterase Portfolio

Corning® Supersomes? Human Carboxylesterase Portfolio

Product catalog summary
Overview
Corning Supersomes™ Human Carboxylesterase Portfolio includes human recombinant drug metabolizing enzymes, specifically human carboxylesterase 1 (hCES1) and carboxylesterase 2 (hCES2). These enzymes are part of the serine esterase superfamily, primarily expressed in the liver and small intestine, and are involved in the metabolism of xenobiotics and endobiotics.
Features
  • Efficient metabolite formation with a long linear time course, suitable for slow metabolizing drug compounds.
  • Hydrolase activity of recombinant enzymes is functionally similar to hCES1 and hCES2 in human liver and small intestine microsomes.
  • High catalytic activity, ideal for high-throughput screening assays, including drug-drug interaction studies.
  • Supports essential assays for FDA new drug registration and pharmacokinetic studies.
  • Manufactured using a baculovirus transfected insect cell expression system.
High Enzymatic Activity
The product line is engineered for efficient metabolite production with long linear metabolite formation times, making it suitable for identifying metabolites in slowly metabolized compounds.
Engineered for Native Activity
Corning’s CES1b, CES1c, and CES2 enzymes mimic native carboxylesterases in human liver and intestine, as demonstrated by hydrolase activity measurements.
Extensive Portfolio
Corning Supersomes are recognized as the industry gold standard, offering a comprehensive portfolio of Phase 1 and Phase 2 recombinant enzymes, including CYPs, UGTs, FMOs, MAOs, NATs, and CESs.
Michaelis-Menten Kinetic Parameters
Table 1 provides kinetic parameters for CES1b, CES1c, and CES2 compared to human liver and intestinal microsomes. CES1b and CES2 show Km values similar to human tissue, indicating their suitability for mimicking native enzyme activity.
Ordering Information
  • CES1b: Cat. No. 453320, 5 mg/mL, 0.5 mL
  • CES1c: Cat. No. 453321, 5 mg/mL, 0.5 mL
  • CES2: Cat. No. 453322, 5 mg/mL, 0.5 mL
Contact Information
For orders and technical assistance in the U.S., contact Customer Service at 800.492.1110 or email [email protected]. For international inquiries, visit www.corning.com/lifesciences to find your nearest Corning office.
Disclaimer
All products are for research use only and not intended for use in humans or for diagnostic or therapeutic procedures.
See more

Catalog excerpts

Corning® Supersomes? Human Carboxylesterase Portfolio-1

Corning® Supersomes™ Human Carboxylesterase Portfolio Human Recombinant Drug Metabolizing Enzymes Human carboxylesterase 1 (hCES1) and carboxylesterase 2 (hCES2) are members of the serine esterase superfamily, exhibiting broad substrate specificity, and involved in xenobiotic and endobiotic metabolism. Human CES1 and CES2 are primarily expressed in the liver and small intestine. Human CES1 is expressed as two major isoforms; hCES1b and hCES1c. Corning Supersomes CES portfolio of human recombinant metabolizing enzymes match the published sequence from the U.S. National Library of Medicine native DNA sequence and provide high levels of enzymatic activity for efficient metabolite production. Features w Facilitates efficient metabolite formation with long linear time course; ideal for slow metabolizing drug compounds. w Ensures hydrolase activity of recombinant enzymes is functionally similar to hCES1 and hCES2 expressed in human liver and small intestine microsomes, respectively. w Delivers high catalytic activity, ideal for robust high-throughput screening assays including drug-drug interaction studies. w Supports essential assays such as reaction phenotyping and enzyme inhibition required for FDA new drug registration and other pharmacokinetic studies appropriate for evaluating pro-drugs and non-CYP pathways of elimination. w Manufactured using baculovirus transfected insect cell expression High enzymatic activity The Corning Supersomes product line is engineered to provide efficient metabolite production with long linear metabolite formation with typical times of >30 minutes, making the products highly suited to identifying metabolites for slowly metabolized compounds. Engineered for native activity Corning’s CES1b, CES1c, and CES2 behave like native carboxylesterases expressed in human liver and intestine as demonstrated by measured hydrolase activity where the Vmax and Km of recombinant hCES1b and hCES2 are similar to those of human liver and small intestine microsomes (shown in Figure 1). Extensive portfolio of Phase 1 and Phase 2 recombinant enzymes Corning Supersomes are recognized worldwide as the “industry gold standard”, with the most extensive portfolio of CYPs, UGTs, FMOs, MAOs, NATs, and now CESs.

 Open the catalog to page 1
Corning® Supersomes? Human Carboxylesterase Portfolio-2

Michaelis-Menten Kinetic Parameters 4-NPA (Substrate) Vmax (nmol/mg/min) 836 North St. Building 300, Suite 3401 Tewksbury, MA 01876 t 800.492.1110 t 978.442.2200 f 978.442.2476 www.corning.com/lifesciences HLM: Human Liver Microsomes HIM: Human Intestinal Microsomes Table 1. Michaelis-Menten kinetic parameters of CES1b, CES1c compared to HLM, and CES2 compared to HIM. CES1b and CES2 measured Km values were found to be similar to Km values obtained using human tissue. When 4-Nitrophenyl Acetate (4-NPA) was used as a substrate the measured Km values for CES1b and HLM were approximately 200 µM....

 Open the catalog to page 2

All Corning Life Sciences catalogs and technical brochures

  1. Cell Culture

    8  Pages

  2. SPS-H70-SR1

    3  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.